2011 Annual Meeting | Cerebrovascular Disease

Date Friday 04/15/11

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Cheryl Bushnell, MD, MHS

Topic(s)

Learning Objectives Participants should be familiar with the latest recommendations and controversies regarding the evaluation and management of patients with all stroke types, including acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage; be able to initiate optimal secondary prevention strategies after ischemic stroke, including selection of the optimal antithrombotic agent using the most recently published data and appropriate aggressive risk factor management; be able to manage intracranial and extracranial large artery occlusive disease, selecting the best surgical or endovascular option; be able to recognize differences in risk factors and outcomes based on gender; and utilize tools to improve the quality of stroke care.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
09:00 AM - 09:45 AM		Contemporary Management of Acute Ischemic Stroke Pooja Khatri, MD, FAAN
09:45 AM - 09:55 AM		Questions and Answers Pooja Khatri, MD, FAAN
09:55 AM - 10:35 AM		Update on Antithrombotic Therapy: Ischemic Stroke and Atrial Fibrillation Moira Kapral, MD
10:35 AM - 10:45 AM		Questions and Answers Moira Kapral, MD
10:45 AM - 11:00 AM		Break
11:00 AM - 11:40 AM		Secondary Stroke Prevention: Evidence Based Risk Factor Management Philip B. Gorelick, MD, MPH, FAAN
11:40 AM - 11:50 AM		Questions and Answers Philip B. Gorelick, MD, MPH, FAAN
11:50 AM - 12:30 PM		Contemporary Management of Intracranial and Extracranial Large Vessel Disease Edward Feldmann, MD
12:30 PM - 12:40 PM		Questions and Answers Edward Feldmann, MD
12:40 PM - 01:40 PM		Lunch
01:40 PM - 02:20 PM		Contemporary Management of Intracerebral Hemorrhage Vineeta Singh, MD, FAAN
02:20 PM - 02:30 PM		Questions and Answers Vineeta Singh, MD, FAAN
02:30 PM - 03:10 PM		Contemporary Management of Subarachnoid Hemorrhage Vineeta Singh, MD, FAAN
03:10 PM - 03:15 PM		Questions and Answers Vineeta Singh, MD, FAAN
03:15 PM - 03:50 PM		Quality Improvement Tools for Improving Stroke Care Eric E. Smith, MD
03:50 PM - 03:55 PM		Questions and Answers Eric E. Smith, MD
03:55 PM - 04:10 PM		Break
04:10 PM - 04:45 PM		Gender Differences in Stroke Risk Factors and Outcomes Cheryl Bushnell, MD, MHS
04:45 PM - 05:00 PM		Discussion

Faculty Disclosures
Pooja Khatri, MD, FAAN	The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Cheryl Bushnell, MD, MHS	Dr. Bushnell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZZ Biotech. The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from AHRQ. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Philip B. Gorelick, MD, MPH, FAAN	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Edward Feldmann, MD	No disclosure on file
Eric E. Smith, MD	Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care.
Vineeta Singh, MD, FAAN	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genae Americas, Inc. .
Moira Kapral, MD	The institution of Moira Kapral, MD has received research support from Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research.

��ɫ��

��ɫ��